According to an experiment performed on human peritoneal mesothelial cells (HPMCs), TGF-β1 inhibition has shown the attenuation of peritoneal fibrosis and reversed TGF-β-mediated changes such as thickening and fibrosis of the peritoneum [22]. This evidence concerns the gene TGFB1 and Peritoneal Fibrosis.